1 Min Read
Sept 18 (Reuters) - OncoCyte Corp
* OncoCyte reports positive analytical validation study results of Determavu lung cancer diagnostic test Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.